pharma is the sole category represented across all 1 tracked stories. Judge Denise Cote is most often covered alongside 2nd U.S. Circuit Court of Appeals, which appears in 1 of these 1 story. Judge Denise Cote appears in 1 tracked Biotech story from July 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Judge Denise Cote
pharma is the sole category represented across all 1 tracked stories. Judge Denise Cote is most often covered alongside 2nd U.S. Circuit Court of Appeals, which appears in 1 of these 1 story. Judge Denise Cote appears in 1 tracked Biotech story from July 25, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Judge Denise Cote. Shared-story counts are live from our verified record — not editorial picks.
The 2nd Circuit ruling revives mass tort litigation linking prenatal acetaminophen to autism, exposing Kenvue and retailers to billions in potential liability. The decision hinges on admissibility of novel scientific evidence, challenging Daubert standards and regulatory orthodoxy.